Healthcare / Medical Care FacilitiesQatar
$5.84
-0.09 (-1.53%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $35.1M · quality 73.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
53/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.6B
P/E
25.4x
↑EV/EBITDA
19.1x
↑ROE
7.4%
↑Gross Margin
35.1%
↓Debt/Equity
0.15
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+1.0%
FCF CAGR
-15.2%
FCF margin
7.0%
FCF / Net income
0.46x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $502.6M · net income $76.0M · FCF $35.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $502.6M | $502.6M | $523.5M | $486.0M | $487.2M |
| Net Income | $76.0M | $76.0M | $60.1M | $65.7M | $79.2M |
| EBITDA | $90.3M | $90.3M | $110.4M | $97.3M | $109.7M |
| EPS | 0.27 | 0.27 | 0.21 | 0.23 | 0.28 |
| Gross Margin | 35.1% | 35.1% | 37.6% | 36.2% | 38.1% |
| Operating Margin | 12.7% | 12.7% | 16.0% | 14.2% | 15.4% |
| Net Margin | 15.1% | 15.1% | 11.5% | 13.5% | 16.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.15 | 0.15 | 0.18 | 0.13 | 0.12 |
| Current Ratio | 1.34 | 1.34 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $35.1M | $35.1M | $54.2M | $24.0M | $57.7M |
| Returns | |||||
| ROE | 7.4% | 7.4% | 6.0% | 6.5% | 7.6% |
| Valuation | |||||
| P/E | 25.39 | 25.39 | 20.70 | 23.83 | 22.52 |
| EV/EBITDA | 19.14 | 19.14 | 11.93 | 17.07 | 16.90 |
| P/B | 1.59 | 1.59 | 1.23 | 1.52 | 1.71 |
| Growth & Yield | |||||
| Revenue Growth | -4.0% | -4.0% | 7.7% | -0.2% | — |
| EPS Growth | 26.8% | 26.8% | -7.4% | -17.9% | — |
| Dividend Yield | 3.7% | 3.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
24.3%
EPS terminal req.
$0.52
Spread vs growth
2.5%
5Y implied EPS CAGR
18.4%
EPS terminal req.
$0.63
Spread vs growth
8.4%
10Y implied EPS CAGR
14.1%
EPS terminal req.
$1.01
Spread vs growth
12.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+20.7%
Start / end P/E
23.4x → 21.6x
EPS bridge
0.21 → 0.27
Residual
-2.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.